DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneSMAvoice.com | ||
If you'd like to unsubscribe and stop receiving these emails click here |
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Progressive Spinal Muscular Atrophy (First Edition)
Spinal muscular atrophy (SMA) is a hereditary condition characterised by muscle wastage (atrophy) and weakness (skeletal muscles). It is caused by the loss of motor neurons, which are specialised nerve cells that control muscular movement. Progressive Spinal Muscular Atrophy (First Edition) provides a wonderful insight on the overview, symptoms, causes, and latest advancements in research regarding the disease. The book covers in depth the latest research information as well as newly discovered potential causes of Progressive Spinal Muscular Atrophy.
Related Content
-
News & MeetingsBaby First at UNC to Receive Gene Therapy for SMA, Thanks to Early Check Newborn ScreeningIt was a pregnancy that went relatively ...
-
EducationRisdiplam for the Use of Spinal Muscular AtrophySpinal muscular atrophy (SMA) is one of ...
-
Community CenterEquipment Donations at SMA ClinicThe Pediatric SMA Clinical Research Cent...
-
EducationCombination Therapy With Nusinersen and Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy Type ISpinal muscular atrophy (SMA) is a neuro...
-
News & MeetingsFDA Grants Evrysdi® Priority Review Based on Results From Treating Pre-Symptomatic Infants With Spinal Muscular Atr...PTC Therapeutics, Inc. announced that th...
-
Videos & VisualsMeasuring the SMA Experience: Laura’s Storyhttps://www.youtube.com/watch?v=LNpcXiiW...
-
News & MeetingsOnce-Daily Risdiplam Beneficial in Patients With Types 2 and 3 SMA: LancetOnce-Daily Risdiplam is beneficial in pa...
send a message
Reset password
password changed successfully!
please log in with your email address and new password.
your activation key expired
this confirmation key has expired. please try to log in again or resend confirmation email.
confirmation email sent
a confirmation email has been sent to your inbox. click the link in the email to activate your account.
can't find the email? be sure to check your spam folder.
password reset email sent
an email has been sent to you with a link to reset your password.
can't find the email? be sure to check your spam folder.
If you are a doctor or other qualified health care professional, you should not offer any medical advice or treatment on our Sites, nor should you allow the content of our Sites to substitute for your own medical judgment. Please thoroughly review the information provided on our Sites before deciding whether any of the products, services, or treatments therein are right for you or others.
your account is now activated!
Log in
This feature is only available to members.
you haven't confirmed your email address yet. resend confirmation email